Market Overview

UPDATE: Stifel Nicolaus Raises PT to $36 on DeVry Following FQ2 Earnings

Related DV
For-Profit Colleges Are Not At All Profitable Investments
Benzinga's Volume Movers
The Best CCC Stocks For 2016 And 2020 (Seeking Alpha)

Stifel Nicolaus reiterated its Buy rating on DeVry (NYSE: DV) and raised the price target from $30.00 to $36.00.

Stifel Nicolaus noted, "DeVry's “transition year” is generally progressing better than expected – beating on revenue, EPS, medical volume metrics, and cost reductions. Expense shift (especially in advertising) to 2H benefited 2Q, but total costs are now expected to be down for the year. Enrollment turn at DeVry University will take time (new enrollment probably does not turn positive by year end) with 2014-2016 targeted as recovery and growth phase. We believe DV is well positioned over the intermediate/long term with focus on high demand programs (medical/technical) and solid value proposition."

DeVry closed at $26.12 on Wednesday.

Latest Ratings for DV

Sep 2015Barrington ResearchUpgradesMarket PerformOutperform
Aug 2015Standpoint ResearchUpgradesHoldBuy
Aug 2015Compass PointMaintainsNeutral

View More Analyst Ratings for DV
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Price Target Analyst Ratings


Related Articles (DV)

View Comments and Join the Discussion!

Get Benzinga's Newsletters